Lupin launches generic Xenazine

Press enter to search
Close search
Open Menu

Lupin launches generic Xenazine

By Sandra Levy - 11/21/2018
Lupin is introducing its generic Xenazine tablets (tetrabenazine). The generic Valeant Pharmaceuticals drug, which will be available in 12.5- and 25-mg dosage strengths, was previously approved by the Food and Drug Administration.

The product is indicated for the treatment of chorea associated with Huntington’s disease.

Xenazine tablets had a market value of $153 million, according to IQVIA September 2018 data.

Related Topics